Synthesis and analysis of novel catecholic ligands as inhibitors of catechol-O-methyltransferase
Bioorganic & Medicinal Chemistry Letters · 2023
DOI: 10.1016/j.bmcl.2023.129286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2023. Verfasst von A Katherine Hatstat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA 94158, USA; Department of Chemistry, Rhodes Coll…. Hauptthemen laut MEDLINE: Dopamine, Levodopa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Science Foundation.
Abstract (Originalsprache)
l-DOPA, a dopamine precursor, is commonly used as a treatment for patients with conditions such as Parkinson's disease. This therapeutic l-DOPA, as well as the dopamine derived from l-DOPA, can be deactivated via metabolism by catechol-O-methyltransferase (COMT). Targeted inhibition of COMT prolongs the effectiveness of l-DOPA and dopamine, resulting in a net increase in pharmacological efficiency of the treatment strategy. Following the completion of a previous ab initio computational analysis of 6-substituted dopamine derivatives, several novel catecholic ligands with a previously unexplored neutral tail functionality were synthesized in good yields and their structures were confirmed. The ability of the catecholic nitriles and 6-substituted dopamine analogues to inhibit COMT was tested. The nitrile derivatives inhibited COMT most effectively, in agreement with our previous computational work. pKa values were used to further examine the factors involved with the inhibition and molecular docking studies were performed to support the ab initio and experimental work. The nitrile derivatives with a nitro substituent show the most promise as inhibitors, confirming that both the neutral tail and the electron withdrawing group are essential on this class of inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, CA 94158, USA; Department of Chemistry, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA.
- Department of Chemistry, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA.
- School of Chemistry, Food and Pharmacy, University of Reading, Reading RG6 6AB, UK.
- Department of Chemistry, Rhodes College, 2000 North Parkway, Memphis, TN 38112, USA. Electronic address: petersonl@rhodes.edu.
Förderung
- National Science Foundation
Zitieren
APA
Katherine Hatstat, A., Kennedy, G. M., Squires, T. R., Xhafkollari, G., Skyler Cochrane, C., Cafiero, M., & Peterson, L. W. (2023). Synthesis and analysis of novel catecholic ligands as inhibitors of catechol-O-methyltransferase. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129286
Vancouver
Katherine Hatstat A, Kennedy GM, Squires TR, Xhafkollari G, Skyler Cochrane C, Cafiero M, et al. Synthesis and analysis of novel catecholic ligands as inhibitors of catechol-O-methyltransferase. Bioorganic & Medicinal Chemistry Letters. 2023. doi:10.1016/j.bmcl.2023.129286
BibTeX
@article{KatherineHatstat2023,
author = {Katherine Hatstat, A and Kennedy, Grace M and Squires, Trevor R and Xhafkollari, Gisela and Skyler Cochrane, C and Cafiero, Mauricio and Peterson, Larryn W},
title = {Synthesis and analysis of novel catecholic ligands as inhibitors of catechol-O-methyltransferase},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2023},
doi = {10.1016/j.bmcl.2023.129286}
}
EUVIMED